Carregant...
Plasma ApoA1 Associates with Age at Onset and Motor Severity in Early Parkinson Disease Patients
BACKGROUND: The development of robust plasma-based biomarkers in Parkinson disease (PD) could lead to new approaches for identifying those at risk for PD and developing novel therapies. Here we validate plasma Apolipoprotein A1 (ApoA1) as a correlate of age at onset and motor severity in PD. METHODS...
Guardat en:
| Publicat a: | Mov Disord |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609229/ https://ncbi.nlm.nih.gov/pubmed/26207725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26290 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|